Expression of stem cell markers in odontogenic cysts and tumors

Authors

DOI:

https://doi.org/10.5327/2525-5711.540

Keywords:

Odontogenic Tumor, Odontogenic Cyst, stem cell, marker

Abstract

This review aims to explore the literature on the presence and participation of stem cells in the pathogenesis and evolution of odontogenic lesions. This narrative review was carried out by searching the PubMed and Medline databases. Articles published between 2010 and 2024 that evaluated the expression of stem cell markers in different odontogenic cysts and tumors were retrieved. In most studies, the expression of stem cell markers was documented by immunohistochemistry and/or immunofluorescence, with Oct4, CD44 and Sox2 being the most commonly studied. The association of stem cells with the development and biological behavior of these pathologies remains uncertain. However, the high immunoexpression of these proteins seems to be related to the maintenance of cells with a stem-like phenotype, morphological diversity of the lesions, tumor initiation and progression, sustained growth, and the aggressiveness of odontogenic lesions. Stem cells are possibly involved in the histopathogenesis, development, and progression of odontogenic lesions. Therefore, stem cells may represent a potential target for future individualized therapies. Further studies in this area are needed to confirm the role of stem cells in odontogenic cysts and tumors.

References

1. Kalogirou EM, Lekakis G, Petroulias A, Chavdoulas K, Zogopoulos VL, Michalopoulos I, et al. The Stem Cell Expression Profile of Odontogenic Tumors and Cysts: A Systematic Review and Meta-Analysis. Genes (Basel). 2023 Sep 1;14(9). doi:10.3390/GENES14091735 PubMed PMID: 37761874.

2. Mamabolo M, Noffke C, Raubenheimer E. Odontogenic tumours manifesting in the first two decades of life in a rural African population sample: A 26 year retrospective analysis. Dentomaxillofacial Radiology. 2011 Sep;40(6):331–7. doi:10.1259/dmfr/54585925 PubMed PMID: 21831971.

3. da Trindade GA, da Silva LP, de Andrade Santos PP, Pinto LP, de Souza LB. Expression of a Tumor Stem Cell Marker (Aldehyde Dehydrogenase 1-ALDH1) in Benign Epithelial Odontogenic Lesions. Head Neck Pathol. 2022 Mar 29;16(3):785–91. doi:10.1007/s12105-022-01430-z

4. Duarte-Andrade FF, Vitório JG, Pereira T dos SF, Gomes CC, Gomez RS. A review of the molecular profile of benign and malignant odontogenic lesions. Oral Surg Oral Med Oral Pathol Oral Radiol. 2020 Apr;129(4):357–68. doi:10.1016/j.oooo.2019.12.017

5. Monroy EAC, de Andrade Santos PP, de Sousa Lopes MLD, Mosqueda-Taylor A, Pinto LP, de Souza LB. Oct-4 and CD44 in epithelial stem cells like of benign odontogenic lesions. Histochem Cell Biol. 2018;150(4):371–7. doi:10.1007/s00418-018-1692-7 PubMed PMID: 29971493.

6. Chacham M, Almoznino G, Zlotogorski-Hurvitz A, Buchner A, Vered M. Expression of stem cell markers in stroma of odontogenic cysts and tumors. Journal of Oral Pathology and Medicine. 2020;00:1–10. doi:10.1111/jop.13102 PubMed PMID: 32840915.

7. Phattarataratip E, Panitkul T, Khodkaew W, Anupuntanun P, Jaroonvechatam J, Pitarangsikul S. Expression of SOX2 and OCT4 in odontogenic cysts and tumors. Head Face Med. 2021 Dec 14;17(1):29. doi:10.1186/s13005-021-00283-1

8. Đokić J, Tomić S, Cerović S, Todorović V, Rudolf R, Čolić M. Characterization and immunosuppressive properties of mesenchymal stem cells from periapical lesions. J Clin Periodontol. 2012 Sep 8;39(9):807–16. doi:10.1111/j.1600-051X.2012.01917.x

9. Paduano F, Marrelli M, Palmieri F, Tatullo M. CD146 Expression Influences Periapical Cyst Mesenchymal Stem Cell Properties. Stem Cell Rev Rep. 2016 Oct 1;12(5):592–603. doi:10.1007/s12015-016-9674-4 PubMed PMID: 27406247.

10. Silva FPY, Dias A, Coelho CA, Guerra EN, Marques AEM, Decurcio D de A, et al. Expression of CD90 and P75NTR stem cell markers in ameloblastomas: a possible role in their biological behavior. Braz Oral Res. 2016;30(1):e109. doi:10.1590/1807-3107BOR-2016.vol30.0109 PubMed PMID: 27737362.

11. Sharpe PT. Dental mesenchymal stem cells. Development (Cambridge) [Internet]. Company of Biologists Ltd; 2016 [cited 2020 Nov 30]. p. 2273–80. Available from: https://pubmed.ncbi.nlm.nih.gov/27381225/ doi:10.1242/dev.134189 PubMed PMID: 27381225.

12. Couto de Carvalho LA, Tosta Dos Santos SL, Sacramento LV, de Almeida VRJ, de Aquino Xavier FC, Dos Santos JN, et al. Mesenchymal stem cell markers in periodontal tissues and periapical lesions. Acta Histochem. 2020 Oct;122(8):151636. doi:10.1016/j.acthis.2020.151636 PubMed PMID: 33132168.

13. Huang GTJ, Gronthos S, Shi S. Mesenchymal Stem Cells Derived from Dental Tissues vs . Those from Other Sources: Their Biology and Role in Regenerative Medicine. J Dent Res. 2009 Sep 18;88(9):792–806. doi:10.1177/0022034509340867

14. Morsczeck C, Götz W, Schierholz J, Zeilhofer F, Kühn U, Möhl C, et al. Isolation of precursor cells (PCs) from human dental follicle of wisdom teeth. Matrix Biology. 2005;24:155–65. doi:10.1016/j.matbio.2004.12.004 PubMed PMID: 15890265.

15. Marrelli M, Paduano F, Tatullo M. Cells isolated from human periapical cysts express mesenchymal stem cell-like properties. Int J Biol Sci. 2013;9(10):1070–8. doi:10.7150/ijbs.6662 PubMed PMID: 24250252.

16. Estrela C, Freitas Silva BS, Silva JA, Yamamoto-Silva FP, Pinto-Júnior D dos S, Gomez RS. Stem Cell Marker Expression in Persistent Apical Periodontitis. J Endod. 2017;43(1):63–8. doi:10.1016/j.joen.2016.09.002 PubMed PMID: 27847139.

17. Kumamoto H, Ohki K. Detection of CD133, Bmi-1, and ABCG2 in ameloblastic tumors. J Oral Pathol Med. 2010 Jan;39(1):87–93. doi:10.1111/J.1600-0714.2009.00807.X PubMed PMID: 19659474.

18. Juuri E, Isaksson S, Jussila M, Heikinheimo K, Thesleff I. Expression of the stem cell marker, SOX2, in ameloblastoma and dental epithelium. Eur J Oral Sci. 2013 Dec;121(6):509–16. doi:10.1111/eos.12095 PubMed PMID: 24148099.

19. Heikinheimo K, Kurppa KJ, Laiho A, Peltonen S, Berdal A, Bouattour A, et al. Early dental epithelial transcription factors distinguish ameloblastoma from keratocystic odontogenic tumor. J Dent Res. 2015;94(1):101–11. doi:10.1177/0022034514556815 PubMed PMID: 25398365.

20. Kumar A, Bhanja A, Bhattacharyya J, Jaganathan BG. Multiple roles of CD90 in cancer. Tumor Biology. 2016 Sep 23;37(9):11611–22. doi:10.1007/s13277-016-5112-0

21. López de Andrés J, Griñán-Lisón C, Jiménez G, Marchal JA. Cancer stem cell secretome in the tumor microenvironment: a key point for an effective personalized cancer treatment. J Hematol Oncol. 2020 Dec 15;13(1):136. doi:10.1186/s13045-020-00966-3

22. Pagella P, Catón J, Meisel C, Mitsiadis T. Ameloblastomas Exhibit Stem Cell Potential, Possess Neurotrophic Properties, and Establish Connections with Trigeminal Neurons. Cells. 2020 Mar 6;9(3). doi:10.3390/CELLS9030644 PubMed PMID: 32155948.

23. Tseng CH, Lu PH, Wang YP, Chang JYF. Enrichment of SOX2-Positive Cells in BRAF V600E Mutated and Recurrent Ameloblastoma. J Pers Med. 2022 Jan 8;12(1):77. doi:10.3390/jpm12010077

24. Júnior JF, de França GM, da Silva Barros CC, Felix FA, da Silva WR, de Lucena HF, et al. Biomarkers involved in the proliferation of the odontogenic keratocyst, glandular odontogenic cyst and botryoid odontogenic cyst. Oral Maxillofac Surg. 2022 Jan 21;26(4):655–62. doi:10.1007/s10006-021-01026-x

25. Martins Balbinot K, Almeida Loureiro FJ, Chemelo GP, Alves Mesquita R, Cruz Ramos AMP, Ramos RTJ, et al. Immunoexpression of stem cell markers SOX-2, NANOG AND OCT4 in ameloblastoma. PeerJ. 2023 Jan 13;11:e14349. doi:10.7717/peerj.14349

26. Pereira T, Shetty SJ, Punjabi V, Vidhale RG, Gotmare SS, Kamath P. Immunohistochemical expression of SOX2 in OKC and ameloblastoma: A comparative study. Journal of Oral and Maxillofacial Pathology. 2023;27(4):685–92. doi:10.4103/jomfp.jomfp_265_23

27. Zeen El-Abdeen HM, Tawfik MAM, Elnagdy SY, Mansour NA. Evaluation of the prognostic role of SOX2 as a tumor stem cell marker in odontogenic cysts and tumors: clinical, radiographic and immunohistochemical correlation. BMC Oral Health. 2025 Dec 1;25(1). doi:10.1186/S12903-025-07065-0 PubMed PMID: 41176605.

28. Mannava C, Manyam R, Kumar NV, Puvvada DNL, Swetha P, Supriya N. Immunohistochemical expression of SOX2 and OCT4 in primary odontogenic keratocyst, recurrent odontogenic keratocyst, and odontogenic keratocyst treated by the decompression technique. Journal of Oral and Maxillofacial Pathology. 2025 Apr;29(2):286–92. doi:10.4103/jomfp.jomfp_254_24

29. Martínez-Marcial LA, Ramírez-Jarquín JO, Villanueva-Sánchez FG, Portilla-Robertson J, Ramírez-Martínez CM, Trejo-Remigio DA, et al. Exploratory Expression Analysis of Stem Cell and Epithelial–Mesenchymal Transition Markers in Ameloblastoma. International Journal of Molecular Sciences 2026, Vol 27, Page 4645. 2026 May 21;27(10):4645. doi:10.3390/IJMS27104645 PubMed PMID: 42196620.

30. Redman RS, Basile JR, Castle JT. SOX2 and cytokeratins 5, 8 and 18 as potential stem cell biomarkers in botryoid odontogenic, lateral periodontal and gingival cysts. Histol Histopathol. 2026;41(9):1515–26. doi:10.14670/HH-25-068 PubMed PMID: 41889346.

Downloads

Published

2026-11-16

How to Cite

1.
Couto LA, Sacramento LV, Castro IJV de A, Almeida Júnior VR de, Santana DCP, Henriques Águida CG. Expression of stem cell markers in odontogenic cysts and tumors. J Oral Diagn [Internet]. 2026 Nov. 16 [cited 2026 Nov. 20];. Available from: https://joraldiagnosis.com/revista/article/view/540

Issue

Section

Review Article